Results 421-440 of 1,160,923 for in 'Dáil debates' OR in 'Committee meetings' (speaker:Eoin Ó Broin OR speaker:Imelda Munster OR speaker:Réada Cronin OR speaker:Richard Bruton OR speaker:Paul Donnelly OR speaker:Duncan Smith OR speaker:Malcolm Noonan OR speaker:Richard Bruton8 OR speaker:Sorca Clarke OR speaker:Hildegarde Naughton OR speaker:Peter Fitzpatrick OR speaker:Aodhán Ó Ríordáin OR speaker:Patrick O'Donovan OR speaker:Pádraig Mac Lochlainn OR speaker:Rose Conway-Walsh OR speaker:Barry Cowen OR speaker:Steven Matthews OR speaker:Carol Nolan OR speaker:Marian Harkin OR speaker:Martin Kenny OR speaker:Denise Mitchell OR speaker:Alan Farrell OR speaker:Johnny Mythen OR speaker:Neasa Hourigan OR speaker:Robert Troy OR speaker:Donnchadh Ó Laoghaire OR speaker:Catherine Martin OR speaker:Mick Barry OR speaker:Jack Chambers OR speaker:Alan Dillon OR speaker:Heather Humphreys OR speaker:Pa Daly OR speaker:Paul McAuliffe OR speaker:Gerald Nash OR speaker:Louise O'Reilly OR speaker:James Lawless OR speaker:Darragh O'Brien OR speaker:Cormac Devlin OR speaker:Micheál Martin OR speaker:Mattie McGrath OR speaker:Peadar Tóibín OR speaker:Dessie Ellis OR speaker:Pauline Tully OR speaker:Jennifer Whitmore OR speaker:Brendan Griffin OR speaker:Thomas Gould OR speaker:Matt Carthy OR speaker:Claire Kerrane OR speaker:James Browne OR speaker:Helen McEntee OR speaker:Stephen Donnelly OR speaker:David Cullinane OR speaker:Martin Heydon OR speaker:Chris Andrews OR speaker:Danny Healy-Rae OR speaker:Matt Shanahan OR speaker:Anne Rabbitte)
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Louise O'Reilly: I thank Mr. Perth for that. For the broader witnesses, my understanding is that the committee has agreed that public consumption of drugs cannot be allowed to increase, as we have heard from other jurisdictions that this has huge impacts when they decriminalise drugs. How can we control public consumption without further stigmatising the people the witnesses are working with? How can those...
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Louise O'Reilly: I agree.
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Louise O'Reilly: It would be overwhelmed.
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Louise O'Reilly: Specifically regarding public consumption and the way that can be managed, my understanding is the committee had agreed that an increase in public consumption should not necessarily be a by-product. How can that be done without further stigmatisation, however? We spoke about stigma and trauma. How can that be done without heaping further stigma on communities that do not need it and cannot...
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Neasa Hourigan: To respond to Mr. D'Arcy's point about decriminalisation, any time we make a suggestion to change the law there is concern on this side of the room about unintended consequences or what it would look like. Professor Comiskey, who appeared before the committee a couple of weeks ago, stated her understanding of the research is that more progressive laws do not necessarily increase use and more...
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Neasa Hourigan: Anyone else? We have heard stories about people finding it difficult to get a GP specifically.
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Neasa Hourigan: He just decided to opt out because he could not be treated with dignity.
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Neasa Hourigan: I presume the outcome of that is, again, a removal of yourself from the situation or a failure to engage when you probably need it most.
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Neasa Hourigan: Am I right in thinking, just having sat on the task force a few times, that one of the answers to this is peer support, namely, that people would have a health advocate to sit with them and bring them back? In Mr. McCarthy's experience, is that something that works?
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Neasa Hourigan: There are not enough people.
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Neasa Hourigan: I am always the boring person who says it is really cost-effective.
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Neasa Hourigan: It is just somebody who rings you up, reminds you not to forget about your appointment and walks in with you.
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Neasa Hourigan: When that happens, in Mr. Perth's experience, what is the language that is used? Is it said the people need to go and get treatment for bipolar first?
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Neasa Hourigan: It is that dual diagnosis thing that they just will not do it.
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Neasa Hourigan: Am I right in thinking that if people go in somewhere with bipolar or whatever it might be to ask for treatment, they will often be told they need to get clean first?
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Neasa Hourigan: It is a catch-22.
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Neasa Hourigan: They would be turned away.
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Paul McAuliffe: I acknowledge the Cathaoirleach's new position. I have no doubt but that she will continue the good work of the previous Chair in chairing this committee and doing it in a cross-party way. Our work in this committee is very important, but so is the way we do our work. It is important and different from other committees. I acknowledge this point. I thank Mr. Gloster and all the team for...
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Paul McAuliffe: I saw a figure regarding the outpatient waiting lists having been reduced by 50,000 people. Mr. Gloster is saying this is a real reduction rather than a validation exercise.